Bruno Quesnel
- Hematology top 0.1%
- Acute Myeloid Leukemia Research 72
- Multiple Myeloma Research and Treatments 25
- Chronic Myeloid Leukemia Treatments 15
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 27
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16
- Oncology top 1%
- Immunology top 1%
- Immunotherapy and Immune Responses 19
-
- Lymphoma Diagnosis and Treatment 29
-
- Acute Lymphoblastic Leukemia research 15
- Co-authors
- Pierre FenauxClaude PreudhommeAurore SaudemontDominique HétuinEric WattelXavier ThuruChristian BaillyF Bauters
- Cited by
- HematologyGeneticsOncology
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Bruno Quesnel
197 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Hematology 3.6k
- Genetics 1.9k
- Oncology 2.6k
- Immunology 1.6k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Bruno Quesnel
This map shows the geographic impact of Bruno Quesnel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Quesnel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Quesnel more than expected).
Fields of papers citing papers by Bruno Quesnel
This network shows the impact of papers produced by Bruno Quesnel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Quesnel. The network helps show where Bruno Quesnel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bruno Quesnel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 6 | |
| 4 | 2022 | 5 | |
| 5 | 2018 | 71 | |
| 6 | 2017 | 62 | |
| 7 | 2015 | 37 | |
| 8 | 2015 | 82 | |
| 9 | 2011 | 13 | |
| 10 | 2009 | 13 | |
| 11 | 2008 | 1 | |
| 12 | 2008 | 43 | |
| 13 | 2007 | 161 | |
| 14 | 2007 | 35 | |
| 15 | 2004 | 6 | |
| 16 | Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study | 2002 | 14 |
| 17 | 2001 | 30 | |
| 18 | Cytogénétique des lymphomes malins en 2000 | 2000 | 3 |
| 19 | Inhibiteurs des cyclines/CDK de la région chromosomique 9p21 et hémopathies malignes | 1998 | 1 |
| 20 | 1994 | 30 |
About Bruno Quesnel
Bruno Quesnel is a scholar working on Hematology, Genetics, Oncology, Immunology and Pathology and Forensic Medicine, having authored 202 papers that have together received 8.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (72 papers), Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (27 papers), Multiple Myeloma Research and Treatments (25 papers), Immunotherapy and Immune Responses (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Acute Lymphoblastic Leukemia research (15 papers). The work is most often cited by research in Hematology (3.6k citations), Genetics (1.9k citations), Oncology (2.6k citations), Immunology (1.6k citations) and Pathology and Forensic Medicine (1.2k citations). Bruno Quesnel has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Pierre Fenaux, Claude Preudhomme, Aurore Saudemont, Dominique Hétuin, Eric Wattel, Xavier Thuru, Christian Bailly, F Bauters, Norbert Vey and Céline Berthon. Their work appears in journals such as Blood, Leukemia Research, Leukemia, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.